Zacks Investment Research on MSN
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
Becton, Dickinson and Company BDX, popularly known as BD, announced the enrollment of the first patient in the XTRACT ...
Zacks Investment Research on MSN
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
Becton, Dickinson and Company BDX, popularly known as BD, announced a multi-year collaboration with Opentrons Labworks, Inc.
BD (Becton, Dickinson and Company) announced the enrollment of the first patient in the XTRACT registry, which is designed to ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
Shares of medical technology company Becton, Dickinson and Company (NYSE:BDX) fell 4.2% in the morning session after RBC Capital initiated coverage on the company with a neutral 'Sector Perform' ...
GlobalData on MSN
FDA approves Teva and Medincell’s bipolar I disorder treatment
The approval is supported by a combination of current clinical data and model-informed drug development techniques.
In its disclosure to the stock exchange, the company said profit declined due to higher finance costs and a sharp increase in customs duties—from 10% to 28%—which contributed to the net loss.
The new facility, built on 914 decimals of land, has a daily production capacity of 110.60 tonnes of paints and 15,000 pieces of plastic containers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback